199 related articles for article (PubMed ID: 9874455)
1. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
2. [Relation of tumor size, lymph node status and prognosis in breast cancer].
Shen ZZ
Zhonghua Wai Ke Za Zhi; 1991 Sep; 29(9):554-7, 589. PubMed ID: 1813258
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of clinical and pathologic detection of axillary metastases in patients with carcinoma of the breast.
Chevinsky AH; Ferrara J; James AG; Minton JP; Young D; Farrar WB
Surgery; 1990 Oct; 108(4):612-7; discussion 617-8. PubMed ID: 2218870
[TBL] [Abstract][Full Text] [Related]
4. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.
Veronesi U; Salvadori B; Luini A; Banfi A; Zucali R; Del Vecchio M; Saccozzi R; Beretta E; Boracchi P; Farante G
Ann Surg; 1990 Mar; 211(3):250-9. PubMed ID: 2106841
[TBL] [Abstract][Full Text] [Related]
5. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
Chen ZL; Wen DR; Coulson WF; Giuliano AE; Cochran AJ
Dis Markers; 1991; 9(5):239-48. PubMed ID: 1724633
[TBL] [Abstract][Full Text] [Related]
6. [Breast recurrence after conservative treatment of cancers of the breast: predictive factors and prognostic significance].
Chauvet B; Simon JM; Reynaud-Bougnoux A; Descamps P; Calais G; Lansac J; Bougnoux P; Le Floch O
Bull Cancer; 1990; 77(12):1193-205. PubMed ID: 2081279
[TBL] [Abstract][Full Text] [Related]
7. Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast.
Margolis DS; McMillen MA; Hashmi H; Wasson DW; MacArthur JD
Surg Gynecol Obstet; 1992 Feb; 174(2):109-13. PubMed ID: 1734568
[TBL] [Abstract][Full Text] [Related]
8. [Primary breast cancer: conservation therapy].
Kuten A; Hilu F; Halpern J; Stein M; Robinson E
Harefuah; 1992 Apr; 122(7):409-14, 480. PubMed ID: 1317331
[TBL] [Abstract][Full Text] [Related]
9. Early stage carcinoma of the female breast and axillary lymph node dissection.
Goldenberg IS
Surg Gynecol Obstet; 1977 Oct; 145(4):562-4. PubMed ID: 897979
[TBL] [Abstract][Full Text] [Related]
10. Tumor size and prognosis of breast cancer with negative axillary nodes.
Ciatto S; Cecchini S; Grazzini G; Iossa A; Bartoli D; Rasponi A
Neoplasma; 1990; 37(2):179-84. PubMed ID: 2342630
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and management of axillary node negative breast cancer.
Henney JE
Compr Ther; 1991 Dec; 17(12):12-6. PubMed ID: 1790658
[TBL] [Abstract][Full Text] [Related]
12. Survival and prognostic factors in node-negative breast cancer: results of long-term follow-up studies.
Rosen PP; Groshen S; Kinne DW
J Natl Cancer Inst Monogr; 1992; (11):159-62. PubMed ID: 1627422
[TBL] [Abstract][Full Text] [Related]
13. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
[TBL] [Abstract][Full Text] [Related]
14. Importance of spicules on clinical staging of carcinoma of the breast.
van Bogaert LJ; Hermans J
Surg Gynecol Obstet; 1977 Mar; 144(3):356-8. PubMed ID: 841452
[TBL] [Abstract][Full Text] [Related]
15. [Predisposing factors for local recurrence after conservative treatment of breast cancer].
Chauvet B; Lemseffer A; Le Pechoux C; Simon JM; Reynaud-Bougnoux A; Body G; Lansac J; Le Floch O
Ann Radiol (Paris); 1990; 33(6):306-12. PubMed ID: 2085266
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of human breast cancer with a new tumour marker MCA: relation to axillary lymph node involvement, metastasis, and survival.
Eskelinen M; Lipponen P; Collan Y
Anticancer Res; 1990; 10(3):591-6. PubMed ID: 1695077
[TBL] [Abstract][Full Text] [Related]
17. [Breast cancer. Treatment. Personal experience].
Darío Fábrega R
Rev Med Panama; 1991 Jan; 16(1):25-32. PubMed ID: 2024052
[TBL] [Abstract][Full Text] [Related]
18. The impact of mitotic index on predicting outcome in breast carcinoma: a comparison of different counting methods in patients with different lymph node status.
Laroye GJ; Minkin S
Mod Pathol; 1991 Jul; 4(4):456-60. PubMed ID: 1924277
[TBL] [Abstract][Full Text] [Related]
19. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions.
Perdue P; Page D; Nellestein M; Salem C; Galbo C; Ghosh B
Surgery; 1992 Jun; 111(6):656-9. PubMed ID: 1595061
[TBL] [Abstract][Full Text] [Related]
20. A ten year study of medullary carcinoma of the breast.
Maier WP; Rosemond GP; Goldman LI; Kaplan GF; Tyson RR
Surg Gynecol Obstet; 1977 May; 144(5):695-8. PubMed ID: 850851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
